EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial Officer
WALTHAM, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for …